On November 21st, the Washington Post ran a Special Report on diabetes, featuring a series of supposedly informative articles. The report was sponsored by Novo Nordisk, a big name (maybe the biggest) in diabetes care. No doubt, they have every interest in getting people off their meds… Continue reading
Category Archives: Diabetes
Metformin is my favorite, downside risks are minimal, and it works so well for type II DM
Reforming health care is a signature issue with the current administration, but even the most ardent proponents of Obamacare would be reluctant to call it a success. Notwithstanding the well-publicized problems, of the countless billions spent on this program, precious little has gone into actual patient care. But really, what should we expect from a system designed by soulless bureaucrats such as “bioethicist” Ezekiel Emanuel and Donald Berwick, former Administrator of the Centers for Medicare and Medicaid Services?
The statins have some problems, they are still promoted as reducing cardiovascular event risk.
The first piece I posted on blood glucose hysteria examined the less-than-stellar scientific evidence behind the notion of tight glycemic control. Many readers—doctors and patients alike—wrote in, and virtually all of the correspondence was favorable. Thus, we follow up with a look at the devastating pitfalls of certain diabetes oral meds.
Well the bad news first–Diabetes is up with obesity, the good news is we are treating it more effectively.
According to the American Diabetes Association, 25.8 million children and adults in the United States—8.3% of the population—have diabetes (90-95% are type 2). This includes 18.8 million who are diagnosed and 7 million who are “undiagnosed.” And, if that weren’t bad enough, the ADA estimates that there are also 79 million so-called “prediabetics” in this country. Much more statistical information—and some elucidation of the dubious methodology behind it is available here.